Schulze Kiana M, Hirai Daniel M, Colburn Trenton D, Craig Jesse C, Musch Timothy I, Poole David C
Department of Kinesiology, Kansas State University, Manhattan, KS 66506, United States of America.
Department of Health and Kinesiology, Purdue University, West Lafayette, IN 47907, United States of America.
Microvasc Res. 2025 Jul;160:104808. doi: 10.1016/j.mvr.2025.104808. Epub 2025 Mar 29.
Whether pre-capillary sphincters are present and regulate red blood cell (RBC) flux at the individual capillary level, especially in skeletal muscle, is controversial. Recently, blockade of K channels using the sulphonylurea glibenclamide (GLI) was demonstrated to reduce muscle blood flow and lower vascular conductance. The present investigation tested the hypothesis that, if pre-capillary sphincters were involved in GLI-induced blood flow reductions, a defined luminal narrowing would be evident in the proximate region of the capillaries.
Videomicroscopy of the spinotrapezius capillary bed was performed under control (Krebs-Henseleit) and GLI (200 μM in Krebs-Henseleit) superfusion. Capillary RBC flux was measured within individual capillaries and their luminal diameter was measured using a calibrated digital ruler at the branch-point and subsequently downstream.
GLI reduced capillary RBC flux by 31% (p = 0.004). Despite the presence of a reduced RBC flux, no detectable reduction or, indeed, any change in capillary luminal diameter was present at any measurement site. The average diameter at the branching point was 4.9 ± 0.3 μm, and at 5, 10, 20 and 50 μm downstream, the average diameters were 4.8 ± 0.4, 4.8 ± 0.5, 5.0 ± 0.7, and 5.2 ± 0.4 μm, respectively and were unchanged by GLI (all P > 0.05).
Accordingly, the absence of any evidence for capillary luminal narrowing or constriction in these data support that the GLI-induced reductions in capillary RBC flux and muscle blood flow occur via upstream effects within the arteriolar bed. Decreases in skeletal muscle microcirculatory RBC flux with this K channel blocker were not regulated by any detectable capillary structural alterations.
在个体毛细血管水平,尤其是骨骼肌中,是否存在毛细血管前括约肌并调节红细胞(RBC)通量存在争议。最近,已证明使用磺酰脲类药物格列本脲(GLI)阻断钾通道可减少肌肉血流量并降低血管传导性。本研究检验了以下假设:如果毛细血管前括约肌参与了GLI诱导的血流量减少,那么在毛细血管的邻近区域会出现明确的管腔狭窄。
在对照(Krebs-Henseleit)和GLI(在Krebs-Henseleit中为200μM)灌注下,对斜方肌毛细血管床进行视频显微镜检查。在单个毛细血管内测量毛细血管RBC通量,并使用校准的数字标尺在分支点及其下游测量其管腔直径。
GLI使毛细血管RBC通量降低了31%(p = 0.004)。尽管RBC通量降低,但在任何测量部位均未检测到毛细血管管腔直径的降低或任何变化。分支点处的平均直径为4.9±0.3μm,在下游5、10、20和50μm处,平均直径分别为4.8±0.4、4.8±0.5、5.0±0.7和5.2±0.4μm,且不受GLI影响(所有P>0.05)。
因此,这些数据中没有任何毛细血管管腔狭窄或收缩的证据,这支持了GLI诱导的毛细血管RBC通量和肌肉血流量减少是通过小动脉床内的上游效应发生的。使用这种钾通道阻滞剂导致的骨骼肌微循环RBC通量降低不受任何可检测到的毛细血管结构改变的调节。